TOP > 外国特許検索 > CONSTRUCTION OF PROTEIN-RESPONSIVE shRNA/RNAi REGULATION SYSTEM UTILIZING RNP MOTIF

CONSTRUCTION OF PROTEIN-RESPONSIVE shRNA/RNAi REGULATION SYSTEM UTILIZING RNP MOTIF

外国特許コード F120006324
整理番号 I029P008WO
掲載日 2012年3月22日
出願国 欧州特許庁(EPO)
出願番号 09831915
公報番号 2390324
公報番号 2390324
出願日 平成21年12月9日(2009.12.9)
公報発行日 平成23年11月30日(2011.11.30)
公報発行日 平成26年10月1日(2014.10.1)
国際出願番号 JP2009070580
国際公開番号 WO2010067811
国際出願日 平成21年12月9日(2009.12.9)
国際公開日 平成22年6月17日(2010.6.17)
優先権データ
  • 2009JP070580 (2009.12.9) WO
  • 特願2008-312951 (2008.12.9) JP
発明の名称 (英語) CONSTRUCTION OF PROTEIN-RESPONSIVE shRNA/RNAi REGULATION SYSTEM UTILIZING RNP MOTIF
発明の概要(英語) An object of the present invention is to provide an RNAi control system using an RNA-protein interaction motif.
The present invention provides an shRNA comprising: a guide strand having a sequence complementary to a target sequence; a passenger strand which forms a duplex with the guide strand; and a linker strand which links the guide strand and the passenger strand, wherein the linker strand comprises an RNP-derived protein-binding motif sequence.
The present invention also provides an RNAi control system comprising: the shRNA; and an RNP-derived protein which specifically binds to a protein-binding motif sequence in the shRNA.
特許請求の範囲(英語) [claim1]
1. A RNAi control system responsive to a protein expressed in a cell, the system comprising: a vector for expression of a shRNA comprising: a guide strand having a sequence complementary to an mRNA of a target sequence; a passenger strand which forms a duplex with the guide strand; and a linker strand which links the guide strand and the passenger strand, the linker strand comprising a Box CD sequence, wherein the binding of a L7Ae protein or L7Ae protein-containing fusion protein expressed in the cell to the shRNA inhibits the cleavage of the shRNA by Dicer.
[claim2]
2. An in vitro RNAi control method responsive to a protein expressed in a cell, the method comprising the step of: introducing into the cell a vector for expression of a shRNA comprising a guide strand having a sequence complementary to an mRNA of a target sequence; a passenger strand which forms a duplex with the guide strand; and a linker strand which links the guide strand and the passenger strand, the linker strand comprising a Box CD sequence, wherein the binding of a L7Ae protein or L7Ae protein-containing fusion protein expressed in the cell to the shRNA inhibits the cleavage of the shRNA by Dicer.
[claim3]
3. The RNAi control system according to claim 1, wherein the target sequence of the shRNA is Bcl-xL mRNA, and the RNAi control system controls the expression of an apoptosis regulatory protein.
[claim4]
4. A shRNA comprising: a guide strand having a sequence complementary to a mRNA of a target sequence; a passenger strand which forms a duplex with the guide strand; and a linker strand which links the guide strand and the passenger strand, the linker strand comprising a Box CD sequence,
wherein in response to a L7Ae protein or L7Ae protein-containing fusion protein expressed in a cell, the cleavage of the shRNA by Dicer is inhibited to control the expression of a protein encoded by the mRNA of the target sequence.
[claim5]
5. The RNAi control system according to claim 1, further comprising a vector for intracellular expression of the L7Ae protein or L7Ae protein-containing fusion protein.
[claim6]
6. The RNAi control system according to claim 1, wherein the target sequence of the shRNA is GFP mRNA.
[claim7]
7. The in vitro RNAi control method according to claim 2, wherein the target sequence of the shRNA is Bcl-xL mRNA, and the RNAi control method controls the expression of an apoptosis regulatory protein.
[claim8]
8. The in vitro RNAi control method according to claim 2, further comprising the step of introducing a vector for intracellular expression of the L7Ae protein or L7Ae protein-containing fusion protein into the cell.
[claim9]
9. A method for quantifying the expression of an intracellular marker protein comprising an L7Ae protein without destroying a cell, comprising the steps of: introducing a shRNA comprising: a guide strand having a sequence complementary to GFP mRNA; a passenger strand which forms a duplex with the guide strand; and a linker strand which links the guide strand and the passenger strand, the linker strand comprising a Box CD sequence; and measuring the fluorescence intensity of the GFP.
  • 出願人(英語)
  • JAPAN SCIENCE AND TECHNOLOGY AGENCY
  • 発明者(英語)
  • INOUE TAN
  • SAITO HIROHIDE
  • KASHIDA SHUNICHI
  • HAYASHI KARIN
国際特許分類(IPC)
欧州特許分類/主・副
  • C12N015/11M
  • M12N310/14
  • M12N310/3519
  • M12N310/531
  • M12N320/50
指定国 Contracting States: AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR
ライセンスをご希望の方、特許の内容に興味を持たれた方は、問合せボタンを押してください。

PAGE TOP

close
close
close
close
close
close